Cargando…

Design and Evaluation of Novel HIV-1 Protease Inhibitors Containing Phenols or Polyphenols as P2 Ligands with High Activity against DRV-Resistant HIV-1 Variants

With the increasing prevalence of drug-resistant variants, novel potent HIV-1 protease inhibitors with broad-spectrum antiviral activity against multidrug-resistant causative viruses are urgently needed. Herein, we designed and synthesized a new series of HIV-1 protease inhibitors with phenols or po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ling, Wen, Jiajia, Dong, Biao, Zhou, Jinming, Hu, Shangjiu, Wang, Juxian, Wang, Yucheng, Zhu, Mei, Cen, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697080/ https://www.ncbi.nlm.nih.gov/pubmed/36430656 http://dx.doi.org/10.3390/ijms232214178

Ejemplares similares

Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study
por: Zhou, Huiyu, et al.
Publicado: (2020)

Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance
por: Aoki, Manabu, et al.
Publicado: (2018)

Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice
por: Antinori, Andrea, et al.
Publicado: (2014)

Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy
por: Antinori, Andrea, et al.
Publicado: (2014)

Multiple Molecular Dynamics Simulations and Energy Analysis Unravel the Dynamic Properties and Binding Mechanism of Mutants HIV-1 Protease with DRV and CA-p2
por: Wang, Ruige, et al.
Publicado: (2022)

Analysis of BENCHMRK 1 & 2 using PhenoSense® assay for darunavir (DRV/r) resistance and exploration of functional monotherapy with RAL vs DRV
por: Rockstroh, J, et al.
Publicado: (2010)

AI-Aided Search for New HIV-1 Protease Ligands
por: Arrigoni, Roberto, et al.
Publicado: (2023)

DRV concentrations and viral load in CSF in patients on DRV/r 600/100 or 800/100mg once daily plus two NRTI
por: Di Yacovo, Silvana, et al.
Publicado: (2014)

Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adults
por: Tashima, Karen, et al.
Publicado: (2014)

Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis
por: Arribas, Jose, et al.
Publicado: (2014)

ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults
por: Orkin, C, et al.
Publicado: (2010)

HIV-1 protease-induced apoptosis
por: Rumlová, Michaela, et al.
Publicado: (2014)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors
por: Zhang, Guo-Ning, et al.
Publicado: (2021)

543. An Integrated Safety Analysis Comparing Once-Daily Doravirine (DOR) to Darunavir+Ritonavir (DRV+r) and Efavirenz (EFV) in HIV-1-Infected, Antiretroviral Therapy (ART)-Naïve Adults
por: Thompson, Melanie, et al.
Publicado: (2018)

Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens
por: Marcelin, AG, et al.
Publicado: (2010)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Proteochemometric Modeling of the Bioactivity Spectra of HIV-1 Protease Inhibitors by Introducing Protein-Ligand Interaction Fingerprint
por: Huang, Qi, et al.
Publicado: (2012)

ReFlexIn: A Flexible Receptor Protein-Ligand Docking Scheme Evaluated on HIV-1 Protease
por: Leis, Simon, et al.
Publicado: (2012)

Ahmpatinin (i)Bu, a new HIV-1 protease inhibitor, from Streptomyces sp. CPCC 202950
por: Chen, Ming-Hua, et al.
Publicado: (2018)

HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells
por: Petkov, Stefan, et al.
Publicado: (2022)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

The evolution of the HIV-1 protease folding stability
por: Ferreiro, David, et al.
Publicado: (2022)

Ultrasound-Promoted One-Pot, Four-Component Synthesis of Pyridin-2(1H)-One Derivatives
por: Yang, Jinming, et al.
Publicado: (2013)

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
por: Larru, Beatriz, et al.
Publicado: (2007)

Identification of Novel HIV 1- Protease Inhibitors: Application of Ligand and Structure Based Pharmacophore Mapping and Virtual Screening
por: Yadav, Divya, et al.
Publicado: (2012)

Whiskers-less HIV-protease: a possible way for HIV-1 deactivation
por: Dayer, Mohammad Reza, et al.
Publicado: (2013)

DNA Readout Viewer (DRV): visualization of specificity determining patterns of protein-binding DNA segments
por: Adam, Krisztian, et al.
Publicado: (2020)

Association of gene polymorphism of SDF1(CXCR12) with susceptibility to HIV-1 infection and AIDS disease progression: A meta-analysis
por: Ding, Jiwei, et al.
Publicado: (2018)

HIV-1 Protease: Structural Perspectives on Drug Resistance
por: Weber, Irene T., et al.
Publicado: (2009)

Molecular Basis for Drug Resistance in HIV-1 Protease
por: Ali, Akbar, et al.
Publicado: (2010)

Dynamical Basis for Drug Resistance of HIV-1 Protease
por: Mao, Yi
Publicado: (2011)

HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe
por: Benko, Zsigmond, et al.
Publicado: (2016)

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
por: Rhee, Soo-Yon, et al.
Publicado: (2016)

Inhibition of HIV-1 Protease by Carpobrotus edulis (L.)
por: Omoruyi, Beauty E., et al.
Publicado: (2020)

HIV-1 protease inhibition potential of functionalized polyoxometalates
por: Flütsch, Andreas, et al.
Publicado: (2011)

The interferon-induced MxB protein inhibits an early step of HIV-1 infection
por: Liu, Zhenlong, et al.
Publicado: (2013)

Design, Synthesis, and Biological Evaluation of Phenol Bioisosteric Analogues of 3-Hydroxymorphinan
por: Li, Ziqiang, et al.
Publicado: (2019)

tert-Butyl 4-carbamoyl-3-methoxyimino-4-methylpiperidine-1-carboxylate
por: Wang, Juxian, et al.
Publicado: (2008)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
por: Fun, Axel, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r5hi0fagn8thhdk8peqf8hnh9u